Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zelsuvmi™ (berdazimer) – New drug approval
January 5, 2024 - Ligand Pharmaceuticals announced the FDA approval of Zelsuvmi (berdazimer), for the topical treatment of molluscum contagiosum (MC) in adults and pediatric patients one year of age and older.
